(Q62821556)

English

Vorinostat (SAHA) in Uterine Sarcoma

clinical trial

Statements

A Pilot Study of Peroral Vorinostat (SAHA) in Patients With Refractory Histone Deacetylase-positive Uterine Sarcoma (English)
0 references
0 references
0 references
0 references
0 references
14 December 2017
0 references
4 February 2019
0 references
3
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit